Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta

QR Code

Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta

Bibliographic Details
Main Authors:	Takechi, Ryu, Galloway, Susan, Wellington, C., Johnsen, R., Dhaliwal, Satvinder, Mamo, John
Format:	Journal Article
Published:	Cambridge University Press 2010
Online Access:	http://hdl.handle.net/20.500.11937/15962

Similar Items

Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)

Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine
by: Galloway, Susan, et al.
Published: (2009)

Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice
by: Takechi, Ryu, et al.
Published: (2009)

Enterocyte Beta Amyloid-Lipoprotein Homeostasis: Implications for Alzheimer's Disease Risk
by: Galloway, Susan
Published: (2015)

The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance
by: Galloway, Susan, et al.
Published: (2009)

The differential effects of fatty acids on enterocytic abundance of amyloid-beta
by: Galloway, Susan, et al.
Published: (2019)

Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats
by: D'Alonzo, Zachary, et al.
Published: (2023)

Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease
by: Galloway, S., et al.
Published: (2008)

Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance.
by: Galloway, Susan, et al.
Published: (2008)

Chylomicron amyloi-beta in the aetiology of Alzheimer's disease
by: Takechi, Ryu, et al.
Published: (2008)

Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats
by: Takechi, Ryu, et al.
Published: (2010)

A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk
by: Takechi, Ryu, et al.
Published: (2010)

Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011)

The effect of exogenous cholesterol and lipid modulating agents on apolipoprotein B and amyloid-beta abundance in the absorptive epithelial cells of the small intestine
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2008)

Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus
by: Takechi, Ryu, et al.
Published: (2008)

The structure and dynamics of plasma high-density lipoproteins and their interactions with the beta-amyloid peptide
by: Malajczuk, Chris
Published: (2022)

Interactive Effects of Dietary Fat and APOE Genotype on Peripheral Amyloid-Beta: Implications for Alzheimer’s Disease Risk
by: D'Alonzo, Zachary John
Published: (2025)

β-Amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding
by: Galloway, Susan, et al.
Published: (2007)

Plasma lipoprotein b-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
by: Mamo, John, et al.
Published: (2008)

The Effect of Atorvastatin, Pravastatin and Ibuprofen on Dietary-Fat Induced Disturbances in Blood-Brain Barrier Function
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)

Differential regulation of sphingolipid metabolism in plasma, hippocampus and cerebral cortex of mice administered sphingolipid modulating agents
by: Giles, Corey, et al.
Published: (2017)

Differential effects of saturated fatty acid, monounsaturated fatty acid and polyunsaturated fatty acid on chylomicron metabolism in the small intestine
by: Galloway, S., et al.
Published: (2008)

Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding
by: Takechi, Ryu, et al.
Published: (2013)

Intimal retention cholesterol derived from apoB48 and apoB100-containing lipoproteins in carotid arteries from WHHL rabbits.
by: Proctor, Spencer, et al.
Published: (2003)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: Implications for dementia risk
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)

Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)

Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue
by: Sharif, Arazu
Published: (2024)

Characterisation of low density lipoprotein subfraction profile and apoe genotype among diabetic patients
by: Bebakar, Wan Mohamad Wan
Published: (2001)

Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction
by: Takechi, Ryu, et al.
Published: (2014)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

Finding chemopreventatives to reduce amyloid beta in yeast
by: Macreadie, I., et al.
Published: (2016)

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels
by: Wahjoepramono, E., et al.
Published: (2011)

ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)

The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism
by: Verdile, Giuseppe, et al.
Published: (2009)

Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
by: Irawati, D., et al.
Published: (2016)

Luteinizing Hormone Levels Are Positively Correlated with Plasma Amyloid-ß Protein Levels in Elderly Men
by: Verdile, Giuseppe, et al.
Published: (2008)

Dietary manipulation and increase in plasma unsaturated fatty acids in sheep
by: Rajion, Mohamed Ali, et al.
Published: (2001)

Cannot write session to /tmp/vufind_sessions/sess_ievqktg93jc1ihn4oo12b78j25